Exome Asset Management LLC Tg Therapeutics, Inc. Transaction History
Exome Asset Management LLC
- $115 Billion
- Q2 2024
A detailed history of Exome Asset Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 251,600 shares of TGTX stock, worth $5.58 Million. This represents 3.9% of its overall portfolio holdings.
Number of Shares
251,600
Previous 230,300
9.25%
Holding current value
$5.58 Million
Previous $3.5 Billion
27.78%
% of portfolio
3.9%
Previous 3.0%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
288Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$304 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$253 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$149 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$80.9 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$72 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.22B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...